HD-OPM Archive
Topics › Statins

Statin use linked to lower liver cancer and decompensation in chronic liver disease

Louis Nervegna · May 19, 2025 · ♥ 9 reactions · 4 comments · original Facebook post
StatinsWeight, visceral & liver fatCancer
AI summary & key facts

JAMA Internal Medicine: statin use associated with lower hepatocellular carcinoma and hepatic decompensation and slower fibrosis progression.

More evidence that statins protect the liver in the long term.

#statinsliverHD #statinsHD #liverHD #livercancerHD #statinscancerHD

Research cited

Statin use is associated with lower risks of hepatocellular carcinoma (HCC) and hepatic decompensation, and improved fibrosis progression in patients with chronic liver disease. Statin Use and Risk of Hepatocellular Carcinoma and Liver Fibrosis in Chronic Liver… (JAMA Intern Med, 2025)

No photo description available.
← newer: Low HDL reflects insulin resistance; lose visceral fat and solder: Review: statins may benefit chronic liver disease and cirrho →